December 15th, 2015

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bioxcel Therapeutics Inc (NQ: BTAI )

47.32 USD -0.75 (-1.56%)
Official Closing Price Updated: 7:56 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Bioxcel Therapeutics Inc

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Implied LABU Analyst Target Price: $160
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
10 Biggest Price Target Changes For Wednesday
KeyBanc lifted QUALCOMM, Inc. (NASDAQ: QCOM) price target from $175 to $180. QUALCOMM shares fell 2.3% to $149.00 in pre-market ... 
Tags Benzinga TFX BTAI
From Benzinga
Noteworthy Tuesday Option Activity: BTAI, SAM, IGT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BioXcel Therapeutics Inc (BTAI), where a total of 2,893 contracts have traded so far,... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ZSAN SLN BNGO
From Benzinga
BioXcel Therapeutics Announces BXCL501 Met the Primary and All Secondary Endpoints in the TRANQUILITY Phase 1b/2 Study for the Acute Treatment of Agitation in Dementia, including Alzheimer’s Disease
From GlobeNewswire News Releases
BioXcel Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
Add Up The Pieces: XBI Could Be Worth $185
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BioXcel Therapeutics Announces Grant by U.S. Department of Defense to Evaluate BXCL501 in Patients Suffering from PTSD
Grant will support clinical studies in patients with post-traumatic stress disorder related to alcohol and substance abuse 
From GlobeNewswire News Releases
BTAI Crosses Below Key Moving Average Level
In trading on Tuesday, shares of BioXcel Therapeutics Inc (BTAI) crossed below their 200 day moving average of $42.38, changing hands as low as $42.12 per share. BioXcel Therapeutics Inc shares are... 
Tags Stocks
From Market News Video
LABU, BIIB, BTAI, BLUE: Large Outflows Detected at ETF
Symbols mentioned in this story: LABU, BIIB, BTAI, BLUE Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Noteworthy Monday Option Activity: SKT, BTAI, PBYI
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Tanger Factory Outlet Centers, Inc. (SKT), where a total of 63,675 contracts have traded so... 
Tags Stocks
From Market News Video
Interesting BTAI Put And Call Options For January 2021
Investors in BioXcel Therapeutics Inc (BTAI) saw new options begin trading this week, for the January 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BTAI... 
Tags Stocks
From Market News Video
BioXcel Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference
From GlobeNewswire News Releases
BioXcel Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Earnings Scheduled For November 12, 2020
Companies Reporting Before The Bell • Redhill Biopharma (NASDAQ:RDHL) is projected to report quarterly loss at $0.16 ... 
Tags FTCH BSQR SDGR
From Benzinga
BioXcel Therapeutics Announces Completion of Pre-NDA Meeting with FDA for BXCL501 for the Acute Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorders
From GlobeNewswire News Releases
BioXcel Therapeutics to Present BXCL701 Clinical Data at the Society for Immunotherapy of Cancer's 35th Anniversary Annual Meeting
From GlobeNewswire News Releases
BioXcel Therapeutics to Host Third Quarter 2020 Operating and Financial Results Conference Call and Webcast
From GlobeNewswire News Releases
Investors Snatch BTAI 10.0% Lower Than Its Secondary Stock Offering
Looking back to 93 days ago, BioXcel Therapeutics Inc (BTAI) priced a 4,000,000 share secondary stock offering at $50.00 per share. Buyers in that offering made a considerable investment into the... 
Tags Stocks
From Market News Video
BioXcel Therapeutics Receives FDA Clearance of IND for Phase 2 Trial with BXCL501 for the Treatment of Agitation Associated with Delirium
Fifth potential indication for BXCL501, an orally dissolving thin film 
From GlobeNewswire News Releases
Look Under The Hood: DWAS Has 18% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Cramer Gives His Opinion On BioXcel, Schrodinger And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said that BioXcel Therapeutics Inc (NASDAQ: BTAI) has all the great buzz ... 
Tags Media ADT Market News
From Benzinga
Noteworthy Wednesday Option Activity: RAD, MNOV, BTAI
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Rite Aid Corp (RAD), where a total of 21,930 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
BioXcel Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
From GlobeNewswire News Releases
How The Parts Add Up: LABU Targets $79
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Benzinga's Top Upgrades, Downgrades For September 2, 2020
Upgrades For Zillow Group Inc (NASDAQ: ZG), Deutsche Bank upgraded the previous rating of Hold to the current rating Buy. In the ... 
Tags Airlines IRTC EQH
From Benzinga
10 Biggest Price Target Changes For Monday
KeyBanc raised the price target on Baidu Inc ADR (NASDAQ: BIDU) from $145 to $155. Baidu shares rose 0.4% to $117.17 in pre-market ... 
Tags Price Target Consumer Discretionary DE
From Benzinga
81 Biggest Movers From Friday
Gainers CureVac N.V. (NASDAQ: CVAC) shares jumped 249.4% to close at $55.90 on Friday after the company priced its IPO at $16 per ... 
Tags DDS GLG PRPL
From Benzinga
Noteworthy Friday Option Activity: WBT, MDC, BTAI
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Welbilt Inc (WBT), where a total of 10,333 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Why BioXcel Therapeutics Stock Is Down Today
Investors were not impressed with the company's latest quarterly update. 
Tags BTAI Market News
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

3257 Dunmore Rd SE
Medicine Hat, AB T1B 3R2

[P] 403.527.1101
[F] 403.528.5696

Print Advertising: 403.528.5650
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2015 The Medicine Hat News, A Division of Continental Newspapers Canada Ltd.